Kyung Nam Pharm Co Ltd (053950) — Cash Flow-to-Debt Ratio
Kyung Nam Pharm Co Ltd (053950) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of ₩81.44 Million could theoretically repay 0% of its total liabilities (₩25.73 Billion) in one year. See Kyung Nam Pharm Co Ltd (053950) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kyung Nam Pharm Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Kyung Nam Pharm Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Kyung Nam Pharm Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Kyung Nam Pharm Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Kyung Nam Pharm Co Ltd. Check 053950 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | ₩-1.68 Billion | ₩47.33 Billion | ▼ -199.3% |
| 2024 | 0.04x | ₩1.84 Billion | ₩51.36 Billion | ▲ +296.4% |
| 2023 | 0.01x | ₩693.30 Million | ₩76.78 Billion | ▲ +461.4% |
| 2022 | 0.00x | ₩71.58 Million | ₩44.50 Billion | ▼ -95.7% |
| 2020 | 0.04x | ₩2.62 Billion | ₩69.29 Billion | ▲ +107.8% |
| 2019 | -0.48x | ₩-6.43 Billion | ₩13.27 Billion | ▼ -569.3% |
| 2018 | -0.07x | ₩-1.75 Billion | ₩24.24 Billion | ▼ -142.0% |
| 2016 | 0.17x | ₩4.89 Billion | ₩28.35 Billion | ▲ +2301.3% |
| 2010 | 0.01x | ₩482.65 Million | ₩67.22 Billion | ▲ +52.2% |
| 2007 | 0.00x | ₩148.79 Million | ₩31.55 Billion | — |